Agios Pharmaceuticals Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ASLN | F | ASLAN Pharmaceuticals Limited | 2.22 | |
AGIO | B | Agios Pharmaceuticals, Inc. | -5.69 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | B | BioShares Biotechnology Products Fund | 3.91 | |
WDNA | C | WisdomTree BioRevolution Fund | 2.42 | |
SBIO | B | ALPS Medical Breakthroughs ETF | 1.79 | |
LABD | F | Direxion Daily S&P Biotech Bear 3X Shares | 1.37 | |
XBI | B | SPDR S&P Biotech ETF | 1.22 |
Compare ETFs
Related Industries:
Biotechnology
- Agios Pharmaceuticals
Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Recent Comments
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
From the Blog
Featured Articles